The Center for Medicare and Medicaid Innovation (CMMI) is now accepting applications for its Innovation Advisors Program. The CMMI, created by the Affordable Care Act, is tasked with “testing new models of healthcare delivery and payment.”
According to eligibility requirements on the CMMI website, the advisors program is seeking professionals employed by a “public health or healthcare facility, institution or department,” including, but not limited to, “physicians, nurses, allied health professionals, instructors and non-clinicians (i.e. health care executives, practice managers) with experience in the healthcare field.” Management experience is considered an asset, and the selection process will consider an individual’s “career achievements”; “pre-existing skill set (and it’s relevance to transforming the healthcare delivery system for Medicare, Medicaid, and CHIP beneficiaries)”; “quality of their proposed innovation project in their home organization or area;” and “their organization’s explicit commitment to their work.”
The key areas of focus for innovation advisors include healthcare economics and finance, population health, system analysis and operations research. As many as 200 individuals will be selected between now and 2012, with the first group of advisors beginning a “six-month intensive orientation and applied research period” beginning this December. CMMI notes that advisors will not become government employees, although an advisor’s home organization will receive a stipend. Advisors will be expected to commit up to 10 hours a week, which includes a mix of on-site, in-person meetings, as well as ongoing meetings conducted remotely.
Given that any changes to the Medicare and Medicaid systems would directly impact pharmaceutical companies, it may be wise for the C-suite to consider participating; the deadline for applications is November 15th.